SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $43.27 | 52-week high | $45.62 |
Prev. close | $42.75 | 52-week low | $34.67 |
Day low | $42.97 | Volume | 59,967 |
Day high | $43.45 | Avg. volume | 39,627 |
50-day MA | $40.74 | Dividend yield | 1.46% |
200-day MA | $40.59 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Pharmaceuticals Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 202.88M |
Net Asset Value (NAV) | $42.71 |
Options? | Yes |
Total Holdings | 45 |
XPH Top Holdings
Symbol | Company | % of Total |
AXSM | AXSOME THERAPEUTICS INC | 4.25% |
VTRS | VIATRIS INC | 4.23% |
ITCI | INTRA CELLULAR THERAPIES INC | 4.19% |
PFE | PFIZER INC | 4% |
BMY | BRISTOL MYERS SQUIBB CO | 3.98% |
JNJ | JOHNSON + JOHNSON | 3.95% |
RPRX | ROYALTY PHARMA PLC CL A | 3.91% |
OGN | ORGANON + CO | 3.9% |
ZTS | ZOETIS INC | 3.87% |
CTLT | CATALENT INC | 3.87% |
XPH Price Returns
1-mo | 8.03% |
3-mo | 9.91% |
6-mo | 3.11% |
1-year | 4.47% |
3-year | -12.97% |
5-year | 20.49% |
YTD | 4.79% |
2023 | 2.97% |
2022 | -9.83% |
2021 | -10.54% |
2020 | 14.68% |
2019 | 25.61% |
XPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |